Refine by:
-
Letter to Congressional Leadership on Mental Health Funding
Letter calling on Congress to reject arbitrary funding levels for non-defense discretionary (NDD) appropriations in FY 2025, and instead fund NDD programs at a level that recognizes rising costs and the need for investments in these important programs, and keeps poison pill policy riders out of the package. -
Letter to Congressional Committee Leadership on Mental Health Funding
Letter to Labor, Health and Human Services, and Education (LHHS-Ed) appropriations subcommittees uplifting the importance of continued funding for the Certified Community Behavioral Health Clinic Expansion Grant program in the Fiscal Year 2025 LHHS-Ed Appropriations bill. -
Letter to FDA on Medication Access
Letter requesting information from the FDA so stakeholders can assist in gathering available data on clozapine prior to the next meeting of the Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs Advisory Committee. -
Letter to Biden Administration on Mental Health Funding and Social Supports
Letter requesting the Biden Administration maximize existing caregiver resources and programs within the federal government with the creation of an Office of Caregiver Health. -
Letter to Congressional Committee Leadership on Medicare and Telehealth
Letter to the House Energy and Commerce Committee leadership to urge a full committee mark up in support of the two-year delay of the six-month in-person requirement to access telemental health services under Medicare. -
Statement on Medication Access and Health Equity
Press release applauding the Supreme Court’s unanimous ruling reversing the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al, expressing support of the FDA’s role in safeguarding patients, and urging the Department of Justice to continue rigorously defending that authority. -
Regulatory Comment to HUD on Criminal Justice, Health Equity and Social Supports
Regulatory comment addressed to Acting HUD Secretary Todman in support of the HUD’s efforts to decrease barriers to HUD housing programs for formerly incarcerated and convicted people as exemplified in the proposed rule, “Reducing Barriers to HUD-Assisted Housing” (FR-6362-P-01). -
Regulatory Comment to HUD on Health Equity and Social Supports
Regulatory comment addressed to Acting HUD Secretary Todman in support of the HUD’s proposed rule, “Reducing Barriers to HUD-Assisted Housing” (FR-6362-P-01), and making recommendations to improve the rule for people with disabilities. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter to House and Senate Committee leadership encouraging Congress to support robust FY 25 funding of at least $740M via the BRAIN Initiative for research on the causes, cures, and prevention of neurological and psychiatric disorders. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter to House and Senate Appropriations Committees requesting $35 million for the CDC, $25 million for the NIH, and $1 million for the NIJ to conduct public health research into firearm morbidity and mortality prevention.